Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT01763346 · ClinicalTrials.gov registry record · NA

Beta Cell Restoration Through Fat Mitigation

A NA study, sponsored by University of Southern California.

Completed
Registry status
NA
Development phase
88
Enrollment target

NCT01763346: Completed NA study, sponsored by University of Southern California.

NCT01763346 is a NA study that has completed, run by University of Southern California. The registered enrollment target is 88 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (94% lower). According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT01763346, a NA study, has completed, sponsored by University of Southern California.

COMPLETED
Registry status
NA
Development phase
88 participants
Enrollment target

Study Summary

Weight loss achieved through gastric banding will be superior to treatment with metformin in preserving or restoring pancreatic beta cell function in people with prediabetes or mild type 2 diabetes.

Primary Outcome

mean plasma C-peptide concentration during clamp steady state, adjusted for mean clamp insulin sensitivity

Interventions

  • DRUG Metformin
  • DEVICE gastric banding

Trial Details

FieldValue
Enrollment Target 88 participants
Start Date 2013-06
Est. Completion 2018-06
Phase NA
University of Southern California

617 total trials

What the finished NCT01763346 record still lists

NCT01763346 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 88 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (94% lower).

The record links to 0 conditions, and to 2 interventions - of which Metformin is the first listed.

NCT01763346 does not publish any study locations in the registry export this page uses.

Frequently Asked Questions

What is clinical trial NCT01763346 about?

NCT01763346 is a clinical study titled "Beta Cell Restoration Through Fat Mitigation". Weight loss achieved through gastric banding will be superior to treatment with metformin in preserving or restoring pancreatic beta cell function in people with prediabetes or mild type 2 diabetes.

What is the current status of trial NCT01763346?

This trial is currently completed. It is a NA study. The enrollment target is 88 participants. The study started on 2013-06. Estimated completion is 2018-06.

What interventions are being tested in trial NCT01763346?

The interventions under investigation include: Metformin (DRUG), gastric banding (DEVICE).

Who is sponsoring clinical trial NCT01763346?

This trial is sponsored by University of Southern California, which has 617 total clinical trials registered on ClinicalTrials.gov.

How this trial's enrollment target compares

Where NCT01763346's enrollment target sits among peer trials

88 972nd of 2000 higher than 1,027 of 2,000 other NA trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT03843463 · 88 participants · Phase 2

    Escitalopram and Language Intervention for Subacute Aphasia

  • NCT04066348 · 88 participants · Phase 2

    TNF-α Treatment of Blast-Induced Tinnitus

  • NCT04331704 · 88 participants · Phase 4

    ANCHORS Alcohol & Sexual Health Study: UH3 Project

  • NCT04536103 · 88 participants

    Multi-Vendor Multi-Site Novel Accelerated MRI Relaxometry

Similar registry start date

  • NCT05988463 · started 2027-01-01 · Phase 1

    Dose-Escalation Study of Artesunate Patients With IPF

  • NCT07219706 · started 2026-12-10 · NA

    Dietary Fiber and Time Restricted Eating

  • NCT02831335 · started 2026-12-01

    Technical Development of Multi-Parametric Renocerebral MRI

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

Source: ClinicalTrials.gov NCT01763346, the US trial registry maintained by the National Library of Medicine. NCT01763346 (small enrollment · none site footprint · completed) retrieved and formatted by PlainTrial, see methodology.